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AVALIAÇÃO DA DEPRESSÃO E DE TESTES NEUROPSICOLÓGICOS EM PACIENTES
COM DISFUNÇÃO TEMPOROMANDIBULAR
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RESUMO
A fim de determinar se existem diferenças neuropsicológicas entre os grupos, o Teste de
Aprendizado Verbal da Califórnia (CVLT) e o Teste do Trigrama de Consoantes de Brown-Peterson
(CCC) foram usados. A depressão foi avaliada pelo Inventário de Depressão de Beck (BDI). Os
testes neuropsicológicos usados não mostraram diferenças estatisticamente significativas entre
os três grupos estudados, o que pode ser devido à baixa proporção de pacientes com educação
pós-secundária (25%). Entretanto, o grupo experimental (Grupos I e II) mostrou índices de
depressão mais elevados (p < 0,05) que o Grupo III. Adicionalmente, o Grupo II mostrou maio-
res índices de depressão (p < 0,01) que o Grupo I, e não foi encontrada diferença estatística
entre os Grupos I e III. Em conjunto, estes resultados sugerem que testes de memória são
altamente dependentes do nível educacional e que não podem ser utilizados em larga escala.
Do mesmo modo, a depressão desempenha um papel importante não só na etiologia, como
também na perpetuação da DTM.
UNITERMOS: temporomandibular disorders; neuropsychological tests; psychological tests;
orofacial pain.
SUMMARY
This cross-sectional retrospective study was undertaken with the primary objective of
finding if there were neuropsychological differences among responding TMD (Group I), non-
responding TMD patients(Group II) as well as controls (Group III). The California Verbal
Learning Test (CVLT) and the Brown-Peterson Consonant Trigram Auditory Memory Test (CCC)
were used. Depression was assessed by the Beck Depression Inventory (BDI-Portuguese
Version). The neuropsychological tests used did not show statistically significant differences
among the three groups studied, which might have been due to the low proportion of patients
with post-secondary education (20%). However, the experimental group (Groups I and II)
showed higher scores on depression (p < 0.05) than Group III. In addition, Group II showed
higher levels of depression (p < 0.01) than Groups I and III, and no statiscal differences were
found between Groups I and III. Taken in combination, these results suggest that memory
tests are highly dependable on the level of education of the participants and cannot be
widespreadly used. Also, depression plays a role not only in the etiology, but also in the
perpetuation of TMD.
UNITERMS: disfunção temporomandibular; testes neuropsicológicos; testes psicossociais; dor
orofacial.
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INTRODUCTION
Temporomandibular disorders (TMD) are cha-
racterized largely by facial pain, which is often
exacerbated by jaw movements. The most prevalent
orofacial pain conditions are musculoskeletal in
origin, and of these, TMD are overwhelmingly the
most common. Despite the high rate of treatment
success, it appears that 2% to 30% of patients do
not improve and may be in fact non-responsive to
therapy, irrespective of the treatment modality used
(Grossi et al.12, 2001). Usually, this failure has been
attributed to a combination of behavioral and
psychosocial factors and their interactions with
pathophysiologic factors associated with TMD. To
date, there is somewhat limited information about
those patients who are non-responsive to treat-
ment; because, understandably, most investi-
gations have focused on the development of
successful symptom management or characteri-
zation of the TMD population (Dworkin et al.7,
1994; Fricton et al.8, 1996). However, a recent
trend in the literature has been to identify and de-
termine the prevalence of psychosocial factors that
may be predictive of a TMD patient’s response to
treatment. Neuropsychologic testing (eg, attention,
learning and memory, motor skills, verbal and non-
verbal kills, comprehension, and expression of
language) has been used in psychiatric and non-
psychiatric populations for objective evaluation of
performance for many years (Goldberg et al.10,
1996; Grossi et al.12, 2001). These tests have also
been used to assess the need for cognitive reha-
bilitation, to predict the course of psychiatric and
non-psychiatric illnesses, and to reduce diagnostic
heterogeneity within disorders. A significantly
increased prevalence of apparent neuropsychologic
deficits (ie, memory, attention, and reaction time
deficits) was found in patients whose TMD arose
following a motor vehicle accident (MVA), in
comparison to patients with non-traumatic or
idiopathic TMD. It has also been demonstrated that
there are more non-responders in this post-trau-
matic group(Goldberg et al.10, 1996). Accordingly,
it was suggested that neuropsychologic deficits may
either play an integral role in mediating poor
treatment outcome or at least may be predictors
of poor treatment response in the post-traumatic
TMD population (Grossi et al.12, 2001).
In light of the foregoing, the primary objective
of this study was to determine the clinical utility of
neuropsychologic tests as predictors of treatment
outcome in subjects with idiopathic muscle-related
TMD (i.e., no history of trauma). This might allow
the assessment of TMD patients prior to mana-
gement in order to predict those patients where
good outcomes might be expected (responding
TMD patients, rTMD) versus those where a poor
treatment outcome might occur (non-responding
TMD patients, nrTMD). Our secondary objective
was to determine whether the traditional signs
and symptoms of TMD, as well as other relevant
psychosocial factors (i.e., depression), could also
be used as predictors of treatment outcome in the
population.
MATERIALS AND METHODOS
Study Design
The present study is retrospective (case-
control) study to assess if neuropsychological
differences and depression are risk factors for the
development and perpetuation of TMD in a
Brazilian population, treated for the condition with
reversible treatments for a period of time ranging
from 6 months to 3 years.
Population
The patient population was comprised by 33
women, age range from 16 to 60 years-old, who
have systematically looked for treatment of TMD
in the Occlusion Clinic at the Faculty of Dentistry,
Catholic University of Rio Grande do Sul (PUCRS),
Brazil. The age- and sex-matched control group
was comprised by individuals who were pain-free
and were looking for esthetic or restorative treat-
ment at the Faculty of Dentistry. Patients were
recalled based on a chart review of previous
diagnosis and treatment in the Occlusion Clinic for
TMD after a period ranging from 6 months to
3 years. Based on their case histories and clinical
examination, patients were selected following the
diagnostic criteria set forth by the Research
Diagnostic Criteria for TMD (RDC/TMD) (Dworkin
& LeResche6, 1992).
Inclusion and Exclusion Criteria
In the experimental group, to be considered for
inclusion in this study, subjects had to fulfill the
following criteria: a) women between the ages of
15 and 60 years-old; b) chief complaint of pain (at
least 4 times/week for at least 4 weeks) in the
temporomandibular joint and/or facial muscle
region; and c) tenderness to palpation of at least
3 sites in the masticatory muscles and/or the
temporomandibular joint region and/or limitation150  •  Revista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005
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in mandibular movement (interincisal opening less
than 40 mm) (Dworkin & LeResche6, 1992; Dao et
al.4, 1994; Grossi et al.12, 2001). Patients were
excluded from consideration for the study if their
pain was the result of an arthritic condition
(osteoarthritis/rheumatoid arthritis), or their
primary pain complaint came about in association
with a traumatic injury. In addition, patients who
had been or were currently under treatment for a
TMD were excluded from the study group. As well,
those with metabolic disorders (diabetes, hyperthy-
roidism), neurologic disorders, vascular disease
(migraine, hypertension), neoplasia, or a history
of psychiatric/drug-abuse conditions were not
considered for the study.
Confounders
Age, gender, marital status, educational level,
occupation, employment status, and income level
were controlled at the analysis stage. In addition,
specific confounders which has been shown in the
literature to affect neuropsychological factors and
depression, such as information regarding the
patient’s lifestyle were also included for assessment
in the analysis stage.
Pain Assessment and Treatment
Outcome Measures
Pain intensity levels of pain were assessed using
100 mm numeric visual scales (NS), which provide
a valid and reliable method of patient’s pain
perception regarding “success” or “failure” of
treatment result (Conti et al.2,2001). The NS
consists of a 100 mm line, where the patient reads
in the left end “no pain” and “worst possible pain
or discomfort” in the right end. In addition, a ver-
bal categorical scale (better, the same, worse) was
used for comparison with the NS. The major
shortcoming of verbal scales is that because they
are categorical, it is difficult to specify the size of
each category and whether the categories are of
equal spacing. This comparison was made in order
to assess if there were major discrepancies between
verbal and non-verbal scales (Grossi et al. 12, 2001)
in order to increase the validity of the results when
comparing them to patient’s self assessment.
Improvement Criteria
Thirty percent reduction as a percentage of the
baseline assessment in pain at rest (100 mm
Numeric Scale) was used as the criteria for
improvement. This cut off point was used, because
in one study approximately seventy percent of
patients had a 30% or more reduction in pain
at rest (Dao et al.4, 1994); which was consistent
with the available literature on TMD treatment
success rate (60-90%). In addition, this level of
improvement in VAS scores (30%) could not be
explained only by variation in measurement
variability (Grossi et al. 12, 2001). Two NS scales
were given to the patients regarding facial
(temporomandibular joint and masticatory muscle
pain areas) pain at rest and pain on chewing. The
results were then divided into three categories:
i) 0 to 39 mm, low-intensity pain; ii) 40 to 69 mm,
medium-intensity pain; and iii) 70 to 100 mm,
high-intensity pain. Due to the fact that NS baseline
records were not available, a pain self-assessment
categorical scale on the treatment result (better,
worse or the same) was also included. The average
pain intensity at rest in patients with TMD has been
reported in the literature as being of medium
intensity after a six-month treatment (average 6 on
a ten-point scale) (Turp et al.27, 1998). Patients who
had low-intensity pain levels, in both scales (pain
at rest or pain on chewing), for the last month,
independently of percentage improvement, were
included in group I (responding TMD or rTMD).
Those who had medium – or high-intensity pain
levels in the last month were included in Group II
(non-responding TMD or nrTMD).
Neuropsychologic Testing
California Verbal Learning Test
This test is a 16-item, 4-category “shopping list”
that can be used to assess a subject’s immediate,
short-term, and long-term memory capacity. This
test also assesses the subject’s ability to categorize
lists, thereby probing the memory strategies of the
individual. Therefore, variables such as semantic
clustering, perseveration, intrusions, and interfe-
rence with short-term and long-term recall were
tested.
Peterson-Peterson Consonant Trigram (CCC)
This test assesses immediate memory recall
during “interference”. Subjects were asked to repeat
3 consonants presented after being challenged with
a continuous mathematical subtraction problem
for 3, 9, or 18 seconds. The total number of correct
consonants repeated were scored, regardless the
order in which the subjects repeated them.
Beck Depression Inventory (BDI)
The BDI is a self-completed symptomatic scale,
with 21 items, each having multiple choices, withRevista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005  •  151
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three choices related to the increasing levels of
depression, in which scores ranging from 0 to 3
are attributed. The sum of the scores of individual
items provide a total score corresponding to the
level of depression, which can be classified as
minimal, light, moderate or severe. In this matter,
the questionnaire is intended to evaluate the
intensity of depression, replacing clinical judg-
ments for a cost-saving, standardized, and con-
sistent numeric score of depression.
Clinical Examination
In order to assess the clinical signs and
symptoms involved in TMD, one experienced cli-
nician in the area of orofacial pain was sufficient.
A single examiner was chosen, because the intra-
examiner Kappa index had been shown to be simi-
lar or higher than the inter-examiner reliability
(0.62) (Dworkin & LeResche6, 1992). Palpation of
the temporomandibular joint and masticatory
muscles were included due to the fact that these
variables have been included in almost every study
of temporomandibular disorders and are part of
the standard examination procedure for TMD
(Dworkin & LeResche6, 1992). The extra oral
examination included palpation of the masseter,
temporalis and sternocleidomastoid muscles, as
well as palpation of the TMJ itself by one examiner.
The extra oral muscle palpation reliability (kappa
= 0.47 to 0.65) indicated acceptable agreement
with calibrated examiners in both symptomatic
and asymptomatic populations, and the TMJ
palpation achieves moderate standards (kappa =
0.47 to 0.52). The intraoral muscle reliability is
lower than the extra oral (kappa = 0.27 to 0.61),
and because of that, intraoral muscle palpation
was not performed.
All scores assigned were based on the patient’s
responses when the sites were palpated (i.e.,
evoked pain reaction). A scale of 0 to III was
established (0 meaning no pain response). A gra-
de I pain response was considered a mild
observance that discomfort was present in that the
patient had to be asked whether pain was felt. A
grade II was assigned when changes in facial
expression connoting a pain reaction (or verbal
pain reaction) were produced (i.e., the patient did
not have to be asked). A grade of III was scored
when definite avoidance to palpation was observed
or when normal palpation force was abated before
the patient reacted too violently. In order to
increase our reliability and for analytical purposes,
scores were recoded into two groups: grade 0-I was
considered as a negative pain reaction score; and
grade II-III was considered as a positive reaction
score.
Protocol
The patients underwent the tests in the
following order: a) reading and signature of the
informed consent form, b) social and demographic
questionnaires, c) clinical pain questionnaires,
d) neuropsychologic testing and e) clinical exami-
nation. Clinical examination was performed last,
because the pain exacerbation after examination
could have influenced our test results.
RESULTS
Population
The final sample was comprised by 63
subjects, divided into three groups. In the expe-
rimental group, patients who improved after
treatment were included in Group I (rTMD,
n = 18, 28.6%); while those who did not improve
were included in Group II (nrTMD, n = 15, 23.8%).
The control group, Group III (n = 10, 47.6%) was
comprised by pain-free subjects. There was no
statiscally significant difference (Kruskal-Wallis,
N.S.) in age among the sample after grouping, being
35.3 years-old (± 13.11) for Group I, 36.5 y.o.
(± 11.10) for Group II, and 38.7 y.o. (± 13.4) for
Group III. Regarding educational level, the majority
of Group I (72.2%) and Group II (66.6%) as well
as the control group (70%) had only up to high
school education and were considered with low-
level of education. Regarding marital status, 44.4%
of Group I was married; against 71.4% in Group
II, and 60% in Group III. No individual in all groups
was divorced, but 14.3% in Group II, or widowed.
The majority of Groups I and III was employed
(64.7% and 70%, respectively); on the other hand,
66.7% of Group II was unemployed. Similarly, a
greater percentage (52.9%) of Group I was consi-
dered of high-income level for our national
standards (greater than 5 minimum wages per
family); when compared to Groups II and III (13.3%
and 30%, respectively). Regarding social variables,
66.6% of Group I reported low-level of physical
activity (exercising less than two times a week),
similar to Groups II and III (66.6% and 70%,
respectively). Conversely, Groups I, II and III have
reported moderate social activity (72.2%, 53.4%
and 60%, respectively). Caffeine consumption has
been reported by patients as low (2 cups or less152  •  Revista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005
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per day) in Groups I, II and III alike (83.3%, 86.6%
and 90%, respectively). Alcohol consumption has
also been reported as none or occasionally (less
than 1 drink per day) by all three groups (100%).
Similarly, cigarette smoking has also been reported
as none or occasionally (less than 1 pack per day)
by Groups I, II and III (100%, 86.6% and 70%,
respectively).
Results of the Kruskal-Wallis Test for
Comparison of Pain on Palpation
Among Groups
In the comparison of pain on muscle palpation
in the groups studied, using the Kruskal-Wallis, it
was verified that statistically significant differences
between Group III versus the other two groups (ex-
perimental) were found in the right (p = 0,013)
and left (p = 0,014) TMJ palpation sensitivity, in
the right (p = 0,006) and left (p = 0,014) tempo-
ral muscle palpation sensitivity; as well as in the
right (p = 0,007) sternocleidomastoid muscle.
Nevertheless, Groups I and II did not differ between
them.
Comparisons Between Pain Scores and
Risk Factors
Comparison between pain scores and risk
factors, using the Mann-Whitney non-parametric
test, have demonstrated that there were no
statistically significant differences between the pain
and physical activity. Nevertheless, it was verified
that there were significant statiscally differences
between pain level and alcohol consumption, social
activity and income level. It was observed that
patients who do not drink alcohol have higher
pain levels in the right TMJ (p = 0.01), left TMJ
(p = 0.01), right temporalis muscle (p = 0.05),
and right sternocleidomastoid muscle (p = 0.01).
Besides that, it was shown that patients who
reported to have low or no social activity had
superior pain level in the right (p = 0.02) and left
masseter muscle (p = 0.02). In addition, patients
who had a family income level up to 5 minimum
wages had superior pain levels in the right (p =
0.043) and left (p = 0.05) TMJ, as well as in the
left masseters (p = 0.021). The remaining tests did
not show statistically significant differences.
Statistically significant were verified in relation to
alcohol (p = 0.04) and cigarette (p = 0.04) con-
sumption among the three groups studied. It was
observed in the control group (Group III) a greater
frequency of alcohol and cigarette consumption.
There were no significant differences in the other
variables.
Neuropsychologic Testing
The Spearman’s correlation coefficient was
used to correlate the test results. The variables
which had statistically significant correlations
were: CVLT-CR versus CVLT-*CL (p = 0.001),
CVLT-CR versus CCC-AL (p = 0.002), CVLT-CR
versus CCC-CR (p = 0.001), CVLT-CL versus CCC-
AL (p = 0.034), CVLT-CR versus CCC-CR (p =
0.001), and CCC-AL versus CCC-CR (p = 0.001).
In all significant results, a positive correlation was
disclosed; that is, the larger the score in one test,
the larger will be the score in all tests.
Depression Scores Among Groups I, II
and III
Significant test results in the BDI (Table 2),
using the Mann-Whitney U Test, were found
between the experimental and the control groups.
Patients in the experimental group had significantly
higher depression scores in the BDI than controls
(p = 0,028). Notwithstanding, other test results did
not show significant results. When comparing
Groups I, II and III, using the Kruskal-Wallis test
(Table1), it was verified that the BDI also showed
statistically significant difference among the three
groups, where Group II differed also statistically
from the other two (p = 0,002); while groups I and
III were non-significant.
TABLE 1 – Results of the Kruskal-Wallis test for
comparison of the Beck Depression Inventory (BDI).
Group Mean  Score 
Standard 
Deviation 
Mean 
Rank 
P 
BDI      
Group I  6.22
A  5.72 18.81  0.002* 
Group II  12.00
B 6.16  30.90 
Group III  4.30
A  3.95 14.40 
Mean scores followed by the same letter do not differ significantly
between them (P < 0.01).
TABLE 2 – Results of the non-parametric Mann-
Whitney test for the comparison of the Beck Depression
Inventory (BDI) scores among groups.
Groups 
Mean 
Score 
Standard 
Deviation 
Mean 
Rank 
P 
BDI      
Experimental 8.85  6.52  24.30  0,028* 
Control 4.30  6.95  14.40 Revista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005  •  153
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Correlation Between Muscle-Articular
Pain and Beck Depression Inventory
Scores (BDI)
The Spearman correlation was used to verify
the correlation between pain to joint and muscle
palpation and depression scores. It was shown
a correlation between pain level in the left TMJs
(p = 0.004), right TMJs (p = 0.013), in the left
(p = 0.006) and right (p = 0.009) sternocleido-
mastoid and in the left (p = 0.004) and right (p =
0.047) temporalis muscles with the BDI scores. In
all significant results, it was observed a positive
correlation, that is, the greater the pain level, the
greater the depression score.
DISCUSSION
Currently, TMD is considered a multifactorial
disorder, in which a number of mechanical, neuro-
physiologic and psychologic factors may influence
as predisposing, initiating and perpetuating factors
(Dworking et al.7, 1994; Suvinen et al.25,1995;
Grossi et al.12, 2001). Very little is still known
about the relationship between TMD with their
neurophysiologic etiology (Tenenbaum et al.26,
2001). The way in which TMD relates to depression
and in which way depression might influence their
beginning and perpetuation has not been eluci-
dated yet (Suvinen et al.25,1995). This fact justifies
more profound studies about the relationship
between TMD and depression as well as about
TMD as a whole.
This study was controlled by age (16 to 60
years of age) and gender (women only) in order to
increase our internal validity for a factor which
could influence our results (Grossi et al.12, 2001),
as well as keeping a good external validity, con-
sidering that previous studies have demonstrated
a larger percentage of women with TMD than men:
Fricton et al.8, 1987 with 74,9%; Lipton et al.15,
1984 with 76.5%.
Our final sample of 43 subjects were divided
into three groups: a) Group I (n = 18, 41.9%),
comprised by TMD patients who improved after
treatment; b) Group II (n = 15, 34.9%), formed
by TMD patients who did not improved after
treatment, and c) Group III (n = 10, 23.2%), our
pain-free group. Groups I and II were classified as
the experimental group, while Group III, as the
control group. The inclusion and exclusion criteria
were set forth in the materials and methods
section.
The sample mean age was 30 years old; 35.3 y.o.
(SD = 13.11) for Group I, 36.5 y.o. for Group II
(SD = 11.1), and 29.4 y.o. for Group III (SD =
10.8). These numbers are similar to previous
studies, like Grossi et al.12, 2001 (mean = 28.3 y.o.)
and Fricton et al.8, 1996 (mean = 36.6 y.o.). The
present study also confirms the results of Greene
et al.11, 1983 who found an increase in TMD signs
and symptoms from the second to the third decade
of life.
Regarding educational level, our sample showed
similar values among the three groups. Approxi-
mately, 25% of subjects had completed elementary
school; around 50%, had completed high school,
and close to 25% had post-secondary education.
When the experimental TMD sample was analyzed
(Groups I and II), approximately 70% did not have
post-secondary education, which characterizes a
low level of education, contrasting with previous
studies ( Grossi et al.12, 2001; Fricton et al.8, 1996)
who showed a majority of individuals with higher
education.
Regarding family income, approximately 50%
of our study group earned from 2 to 5 minimum
wages, which is a low-income in our country.
Indeed, 15% had a very low-income, ranging from
0 to 1 minimum wage. Only 10% of our sample
had a income higher than 11 minimum wages.
These numbers allowed us to concluded that this
was predominantly low-income group (70%),
earning from 0 to 5 minimum-wages. Grossi et
al.12, 2001, in a Canadian sample, has shown that
the majority of the sample (57%) had high-income,
contrasting with the present study. Cross-cultural
comparisons between a North-American and a
Brazilian samples are difficult, due to the obvious
social and economic differences between the two.
Social and demographic variables, such as age,
income, marital status and employment were not
statistically different (Chi Square test) between the
experimental and the control groups. In the overall,
the demographic analysis was similar to previous
studies found in the TMD literature.
Exercise, social activity and coffee consumption
was not significantly different between experimen-
tal and control groups. Regarding alcohol con-
sumption, the experimental group had a signi-
ficantly lower level of intake (Chi Square test, p =
0.044) when compared to controls. Cigarette
consumption also disclosed a significant difference
when compared to controls (p = 0.04). The lite-
rature has found no relationship between TMD and
patients life style; therefore, our findings related
to cigarette and alcohol consumption were sur-154  •  Revista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005
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prising. In theory, the results should be similar or
even higher for the experimental group; because it
has a disorder which involves psychosocial factors,
which stimulates alcohol and cigarette consump-
tion. One explanation might be the fact that patients
tend to hide personal information on drugs, alcohol
and cigarette abuse fearful of discrimiation.
The clinical procedures used in this study were
based on the RDC/TMD guidelines (Dworkin &
LeReche.6, 1992). Palpation of the TMD and mas-
ticatory muscles were included, due to the fact that
these variables are included in the majority of TMD
studies and are part of a standardized evaluation
procedure. Extra-oral muscle palpation offers re-
producibility when performed by calibrated exa-
miners, both in symptomatic as well as in asympto-
matic populations (Kappa = 0,47 a 0,65).
In the comparison of pain on muscle palpation
in the groups studied using the Kruskal-Wallis, it
was verified that statistically significantly diffe-
rences between Group III versus the other two
groups (experimental) were found in the right (p =
0,013) and left (p = 0,014) TMJ palpation sensi-
tivity, in the right (p = 0,006) and left (p = 0,014)
temporal muscle palpation sensitivity; as well as
in the right (p = 0,007) sternocleidomastoid
muscle. Nevertheless, Groups I and II did not differ
between them.
Comparison of the pain level among the groups
has shown that statistically significantly differences
between Group III versus the other two groups (ex-
perimental) were found in the right (p = 0,013)
and left (p = 0,014) TMJ, in the right (p = 0,006)
and left (p = 0,014) temporal muscle, as well as in
the right (p = 0,007) sternocleidomastoid. Never-
theless, Groups I and II did not differ between
them.
This also contrast with a previous study
(Grossi et al.12, 2001), where it was not possible
to distinguish between responding versus non-
responding TMD patients by means of palpation
of the TMJ and masticatory muscles.
The fact that at least 20% of TMD patients
are non-responding to treatment and that these
patients share similar characteristics with other
types of chronic pain syndromes, (Goldberg et al.10,
1996; Grossi et al.12, 2001;Tenenbaum et al.26,
2001) led us to study and analyze the neuro-
psychologic aspects of these patients. According
to Stuss et al., 1989, with the right use of
neuropsychologic tests, we will have an objective
description of what areas of behavior and cognition
might or not be associated to non-responding
chronic pain treatment. Goldberg et al.10, 1996,
comparing idiopathic versus post-traumatic TMD
patients, showed statistically significant differences
in the neuropsychologic tests used: a) CVLT-CR
(p < 0.05) and CCC (p < 0.001). Grossi et al.12,
2001, studying responding versus non-responding
idiopathic TMD populations had also significant
results between them in some neuropsychologic
tests: a) CVLR-CL (p < 0.01), CVLT-CR (p < 0.05)
e CCC (p< 0.01).
Contrasting with the studies by Goldberg et
al.10, 1996; Grossi et al.12, 2001; the present study
significant results were not found between res-
ponding and non-responding TMD in our sample
in all neuropsychologic tests used (CVLT-CR, CVLT-
CL, CCC-AL e CCC-CR). Nevertheless, it was
observed a positive correlation between the neuro-
psychologic tests used, showing a similar results
among the different groups. Therefore, it is not true
to state that non-responding TMD patients have
neuropsychologic deficits. This fact might be
related to the level of education of our sample,
where 70% of them did not have post-secondary
education. Based on these results, it can be
concluded that some of these tests, particularly
those involving cognition, might not adequate to
be applied in a population with low level of
education, contrasting with a well-educated North
American population. New studies in a well-
educated Brazilian Population are needed.
Based on the biopsychosocial model, TMD
must be understood as the result of a complex
interaction among biologic, psychologic and social
variables (Dworking et al.7, 1994). It is also known
that depression is present in a great proportion of
TMD patients; nevertheless, a cause and effect
relationship cannot be established at this time,
considering that both chronic pain and depression
share similar pathophysiologic basis (Romano
et al.22, 1985). Indeed, statistically significant
difference (Mann-Whitney U test, p = 0.028) in the
BDI between the experimental and control groups
have been found in this study, with TMD patients
showing higher depression scores than asympto-
matic subjects. When comparing responding versus
non-responding TMD patients and controls
(Groups I, II and III), it was found that Group II
differed significantly from the other two groups (the
Kruskal-Wallis test, p = 0.002), indicating that
depression might be playing a role as a perpe-
tuating factor. A positive correlation was actually
found between BDI scores and pain on palpation
levels at the TMJ, temporalis and sternocleido-
mastoid on both sides, the latest with the highest
association. These results clearly indicated thatRevista Odonto Ciência – Fac. Odonto/PUCRS, v. 20, n. 48, abr./jun. 2005  •  155
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depression might have influenced the treatment
outcome in Group II. However, further studies must
be carried out to elucidate this association. It
is also important that once the patients score
high on the BDI, they must be referred to the
appropriate physician for treatment, because
depression has a major impact on the patient’s
quality of life and can be in some cases life-
threatening (Korszun et al.14, 1997).
Based on our data, it can be concluded that
TMD is a multifactorial disorder, in which psycho-
social factors do play an important role in the
initiation and perpetuation of the related sings and
symptoms. In this way, reversible therapies and
multidisciplinary teams should be employed,
particularly in non-responding TMD patients.
CONCLUSIONS
The results of this study allow us to conclude
that the majority of the neuropsychologic tests used
did not demonstrate statistically different results
in the populations studied. However, BDI scores
which measure depression, have shown statis-
tically significant differences between the experi-
mental (TMD) and control groups. There were
also significant differences in depression scores
between non-responding TMD patients versus res-
ponding-TMD patients and asymptomatic subjects
(controls). However, no statistically significant
difference was found in the BDI between res-
ponding-TMD patients and controls. Therefore,
depression does play a role as a initiating factor in
all TMD patients, and as a perpetuating factor in
non-responding TMD patients.
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